The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*
Abstract
To determine whether hyperinsulinemia can directly reduce serum sex hormone-binding globulin (SHBG) levels in obese women with the polycystic ovary syndrome, six obese women with this disorder were studied. Before study, ovarian steroid production was suppressed in each woman by the administration of 7.5 mg of a long-acting GnRH agonist, leuprolide depot, im, on days -56, -28, and 0. This resulted in substantial reductions in serum concentrations of testosterone (from 1.72 +/- 0.29 nmol/L on day -56 to 0.32 +/- 0.09 nmol/L on day 0), non-SHBG-bound testosterone (from 104 +/- 16 pmol/L on day -56 to 19 +/- 5 pmol/L on day 0), androstenedione (from 7.25 +/- 1.65 nmol/L on day -56 to 2.78 +/- 0.94 nmol/L on day 0), estrone (from 371 +/- 71 pmol/L on day -56 to 156 +/- 29 pmol/L on day 0), estradiol (from 235 +/- 26 pmol/L on day -56 to 90 +/- 24 pmol/L on day 0), and progesterone (from 0.28 +/- 0.12 nmol/L on day -56 to 0.08 +/- 0.02 nmol/L on day 0). Serum SHBG levels, however, did not change (18.8 +/- 2.8 nmol/L on day -56 vs. 17.8 +/- 2.6 nmol/L on day 0). While continuing leuprolide treatment, the women were administered oral diazoxide (300 mg/day) for 10 days to suppress serum insulin levels. Diazoxide treatment resulted in suppressed insulin release during a 100-g oral glucose tolerance test (insulin area under the curve, 262 +/- 55 nmol/min.L on day 0 vs. 102 +/- 33 nmol/min.L on day 10; P less than 0.05) and deterioration of glucose tolerance. Serum testosterone, androstenedione, estrone, estradiol, and progesterone levels did not change during combined diazoxide and leuprolide treatment. In contrast, serum SHBG levels rose by 32% from 17.8 +/- 2.6 nmol/L on day 0 to 23.5 +/- 2.0 nmol/L on day 10 (P less than 0.003). Due primarily to the rise in serum SHBG levels, serum non-SHBG-bound testosterone levels fell by 43% from 19 +/- 5 pmol/L on day 0 to 11 +/- 4 pmol/L on day 10 (P = 0.05). These observations suggest that hyperinsulinemia directly reduces serum SHBG levels in obese women with the polycystic ovary syndrome independently of any effect on serum sex steroids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperinsulinaemia also plays an indirect role in hyperandrogenism by inhibiting hepatic sex hormone-binding globulin (SHBG) production, thus increasing free testosterone (Kiddy et al., 1989;Nestler et al., 1991).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Nestler et al., 1991
In the citing paper
“The result of IR is hyperinsulinemia, which has a central role in the pathogenesis of androgen excess in PCOS.”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [6]
Citations
Cites
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,197
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
Burghen, G. A., Givens, J. R., & Kitabchi, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Self-citationBarbieri, R. L., Makris, A., Randall, R. W., Daniels, G. H., Kistner, R. W., & Ryan, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 629
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Self-citationKIDDY, D. S., SHARP, P. S., WHITE, D. M., SCANLON, M. F., MASON, H. D., BRAY, C. S., POLSON, D. W., REED, M. J., & FRANKS, S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00857.x · Cited by 364
Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease
DeVane, G. W., Czekala, N. M., Judd, H. L., & Yen, S. S. C. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(75)90081-2 · Cited by 338
Cited by
Sorted by citations
Items 701–800 of 814
Cardiovascular risk in young women with Polycystic OvarySyndrome
Coulson, R.-M. K. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Recomendaciones para el diagnóstico y el seguimiento del síndrome de ovarios poliquísticos
Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(08)70803-8
The significance of the first Latin American Consensus on polycystic ovary syndrome
Stadtmauer, L. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02314.x
Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care
Samraj, G. P. N., & Kuritzky, L. (2002) · Comprehensive Therapy · doi:10.1007/s12019-002-0030-z
Illness Perceptions of Polycystic Ovary Syndrome
Baker, E. A. (2014) · Digital Commons - University of South Florida (University of South Florida)
Serine Phosphorylation, Insulin Resistance, and the Regulation of Androgen Synthesis
Bremer, A. A., & Miller, W. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_8
Use of Metformin in Clomiphene Citrate (CC) Resistant Polycystic Ovary Syndrome (PCOS)
Begum, M. R., Banu, L. A., Rumana, R., Dewan, F., & Rouf, S. (2009) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1035
Lebrun, C. E. I. (2008) · EUR Research Repository (Erasmus University Rotterdam)
Störungen des Androgenhaushalts
Leidenberger, F. A. (1998) · Springer eBooks · doi:10.1007/978-3-662-08108-2_17
Serum leptin in polycystic ovarian syndrome with reference to insulin level
Sarkar, C., Subhankar, C., & Kumar, L. T. (2007)
perspectivas Resistência à Insulina na Pubarca Precoce - Relação com os Androgênios
Teixeira, R. J., Gazolla, H. M., da Cunha, S. B., Alice, M., Bordallo, N., & Guimarães, M. M. (2001)
Difficulties and complication of ovarian stimulation
Aboulghar, M. A., & Rizk, B. R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762390.012
Dhanalakshmi, G., Palaniswamy, S., Pasupathi, P., & Ganadeban, M. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)
Evaluation of metformin treatment in patient with polycystic ovary syndrome in Kirkuk city
Mohammed, T., AL-Mandalawi, S., Sabah, I., Azzo, E., Gassan, I., & qadir, N. (2012) · Zanco Journal of Medical Sciences · doi:10.15218/zjms.2012.0009 · Cited by 1
Sultana, R., Marakani, L. R., & Gundabattula, S. R. (2011) · International Journal of Infertility & Fetal Medicine · doi:10.5005/jp-journals-10016-1028 · Cited by 1
Relationship between diets glycemic load and acne
Comin, A. F., & Santos, Z. E. D. A. (2011)
Definition, Clinical Manifestations, and Prevalence
Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2010)
Menstruation in Diabetes Mellitus: A Study from South India
Nagamani, G. (2015) · Journal of Diabetes Research and Therapy · doi:10.16966/2380-5544.103
Hayes, F. J., & Hall, J. E. (2002) · CRC Press eBooks · doi:10.1201/b15291-10
Reproductive endocrinology and infertility
OLSEN, M. E., & Rizk, B. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316084380.027
The endometrium of polycystic ovary syndrome
Giudice, L. C., & Lessey, B. A. (2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203091500.046
New routes in the polycystic ovary syndrome labyrinth
Moghetti, P., & Castello, R. (1998)
Practical Approach to the PCOS Patient
Romanski, P. A., & Stanic, A. K. (2017) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-017-0190-6
Dietary management of Polycystic ovary syndrome.
Moran, L. (2007) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Infertility and Subfertility Cofactors in Women with PCOS
Shavit, T., & Tulandi, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-45534-1_6
ROL DE LA RESISTENCIA A LA INSULINA EN LA PATOGENESIS DEL SÍNDROME DE OVARIO POLIQUÍSTICO
Celis, A. (2015) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v45i635
Endocrinologie de l'obésité : relation avec l'alimentation
Morisset, A. (2008)
Nokoff, N., Thurston, J. E., Hilkin, A. M., Pyle, L., Zeitler, P. S., Nadeau, K. J., Santoro, N. F., & Kelsey, M. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/497339
The effect of metformin on clinical features of women with polycystic ovary syndrome
Bilibajkić, M., Antić, I. B., & Μacut, D. (2018) · Medicinski podmladak · doi:10.5937/mp69-17816
Jafari-Sfidvajani, S. J., Ahangari, R., Hozoori, M., Mozaffari–Khosravi, H., Fallahzadeh, H., & نجارزاده, آ. (2019) · Qom Univ Med Sci J · doi:10.29252/qums.12.11.2
Síndrome dos ovários policísticos e doença hepática gordurosa não alcóolica: o que sabemos?
Pinto, F. H. A. D. M., Nardelli, M. J., Elias, M. L. C., Santos, B. C., Couto, C. A., Rocha, A. L. L., & Faria, L. C. (2019) · Revista Médica de Minas Gerais · doi:10.5935/2238-3182.20190033
Insulin Resistance, Diabetes, Mood and Binge Eating
Barry, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30290-0_5
Obesity and women health: from womb to tomb
Garg, S., Grover, S., & Garg, N. (2020) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20204336
Mlinar, B., Pfeifer, M., Jensterle, M., & Marc, J. (2008)
Mikrobiom und Stoffwechsel beim polyzystischen Ovarialsyndrom (PCOS)
Heizmann, W. R., & Keck, C. (2021) · Der Gynäkologe · doi:10.1007/s00129-021-04829-x
A STUDY ON INSULIN RESISTANCE AND ITS ASSOCIATION WITH OBESITY IN POLYCYSTIC OVARY SYNDROME
Purohit, A., & Soni, Y. (2021) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/0205105
Patten, R. K. (2021) · Victoria University Research Repository (Victoria University)
Вороненко, Н. Ю. (2013) · Medicni perspektivi · doi:10.26641/2307-0404.2013.3.19000
Body Fat, Fat Topography and Endogenous Steroid Dynamics
SNOW, R. C. (1994) · Springer eBooks · doi:10.1007/978-1-4615-2445-8_16
Hormonanalytik zur Zyklusdiagnostik
(2005) · Springer eBooks · doi:10.1007/3-540-26735-2_3
Faculty Opinions recommendation of Role of diet in the treatment of polycystic ovary syndrome.
Mansour, D. (2006) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14722.472238
Ehrmann, D. A., & Sam, S. (2022) · doi:10.1093/med/9780198870197.003.0160
Polycystic Ovary Syndrome and Metabolic Syndrome
Carreau, A., Pesant, M.-H., & Baillargeon, J. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_16
(2007) · Elsevier eBooks · doi:10.1016/b978-032304601-5.50037-x
Hormonanalytik zur Zyklusdiagnostik
(2007) · Springer eBooks · doi:10.1007/978-3-540-70979-4_3
Legro, R. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_9
Nelson, S. M., & Grudzinskas, J. G. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3120-5.00010-2
Polycystic ovary syndrome: metabolic aspects
Legro, R. S. (2011) · doi:10.1093/med/9780199235292.003.0857
Nestler, J. E., & Laganà, A. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_16
Self-citationSoto, A., Iglesias, M. J., Buño, M., & Bellido, D. (2008) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(08)76262-4
Leite, J. M., de Araújo, R. H. C., Silva, E. P. G. E., Teixeira, A. V. O., Peres, M. L., Moreira, C. F., & Cruz, J. F. (2022) · Brazilian Journal of Health Review · doi:10.34119/bjhrv5n3-239
An Insight on Polycystic Ovary Syndrome (PCOS) and Use of Herbal Medicines as Alternative Treatment
Rao, S. K. (2022) · IGI Global eBooks · doi:10.4018/978-1-6684-6299-7.ch007
Exercise interventions in women with Polycystic Ovary Syndrome
Moreno‐Asso, A., Patten, R. K., & McIlvenna, L. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89843-0.00020-9 · Cited by 1
Katti, N., Paprocki, E. L., Amory, J. K., & Prasad, B. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2099839
Polikistik Over Sendromlu Kadınlarda İnsülin Direnci ile Serum Copeptin Düzeyi Arasındaki İlişki
Canbolat, K. H., Gök, K., Tüten, N., Köse, O., Kücür, M., Ekmekçi, Ö. B., Açıkgöz, A. S., Öncül, M., & Tüten, A. (2022) · Sakarya Medical Journal · doi:10.31832/smj.1113885
Polycystic Ovary Syndrome: Effect of Inositols and Lipid Mediators. Pilot Study
Manuel, G. M., Ceamanos, C., Ainhoa, C., & Gema, P. (2023) · Acta Scientific Women s Health · doi:10.31080/aswh.2023.05.0461
Efficacy of metformin treatment in polycystic ovary syndrome
Jerenec, K., Samojlenko, M., Geršak, K., & Ferk, P. (2021) · Acta Medico-Biotechnica · doi:10.18690/actabiomed.87
Islam, R., & Saha, T. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815123975123010004
Vieira, E. P., Lima, F. B. D. C., Pereira, M. S., da Hora, A. F. L. T., Melo, J. S., & Barros, P. D. T. S. (2023) · Revista Foco · doi:10.54751/revistafoco.v16n7-076
Insulinresistenz, Diabetes, schlechte Laune und Essanfälle
Barry, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-24461-2_5
Role of Vitamin D in the treatment of polycystic ovarian syndrome: A systematic review
Swati, S., Choudhary, A., & Singh, H. (2023) · Southeast Asian Journal of Case Report and Review · doi:10.18231/j.sajcrr.2023.018
Yu, R. (2023) · Endocrinology and Disorders · doi:10.31579/2640-1045/136
岳, 玺. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142635
Hormonelle Regulation des menstruellen Zyklus und ihre Störungen
Ludwig, M. Z., & Weiss, J. M. (2024) · Springer eBooks · doi:10.1007/978-3-662-65517-7_3
"Role of Diet Therapy in the Treatment of Polycystic Ovary Syndrome (PCOS)"
Khan, A. S. (2024) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2024.55.008719
Barber, T. M., Hanson, P., & Franks, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-62491-9_7
The Role of Visfatin in Female Reproduction and Various Types of Gynecological Cancers
Koutsoura, K., Kaparos, G., Triantafyllidou, O., & Baka, S. G. (2025) · Current Women s Health Reviews · doi:10.2174/0115734048343364250303044156
Wei, S., Ge, P., Hu, H., & Song, Y. (2025) · Asia Pacific Journal of Clinical Medical Research · doi:10.62177/apjcmr.v1i3.516
Matsuda, E., Matsuda, T., Kojo, K., Osaki, Y., Suzuki, Y., Suzuki, H., Mathis, B. J., Sekiya, M., Nishiyama, H., & Shimano, H. (2025) · Cureus · doi:10.7759/cureus.92180
Lipohyperplasia Dolorosa and Obesity
Faerber, G. (2025) · Springer eBooks · doi:10.1007/978-3-031-77734-9_31
Uterine Origins and Evolution in Childhood
Tsatsoulis, A. A., & Xita, N. V. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_7
Recommended Therapies for Metabolic Defects in Polycystic Ovary Syndrome
Norman, R. J., Ruifrok, A. E., Moran, L., & Robker, R. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_16
多毛, 月経異常, 肥満を伴った糖尿病にトログリタゾンが有用であった1例
小山, 一., 康洋, 斎., & 誠, 青. (2000) · 医療 · doi:10.11261/iryo1946.54.235
Hyperinsulinism, Insulin Resistance and Fertility
Espinós, J. J., & Calaf, J. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50025-5
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648916
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648943
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648934
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648922
Syndrome des ovaires polykystiques
Hugues, J. (2011) · Springer eBooks · doi:10.1007/978-2-8178-0061-5_17
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648949
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648931
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648940
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648946
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648919
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648913
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648928
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648925
Clinical Consequences of Abnormal Glucose Metabolism
Jensen, D. M., Ovesen, P., & Catalano, P. M. (2012) · Springer eBooks · doi:10.1007/978-3-642-25023-1_3
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648937
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648910
Diagnostic and predictive biomarkers of polycystic ovary syndrome in Nigeria: a mini-review
Suleiman, H. A., & Ayodeji, A. S. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00315-3
Vélayoudom‐Céphise, F. (2012) · doi:10.70675/25757912z8b37z4273zb275zcc29c39176f2
Metadata
- Authors
- NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G.
- Affiliations
- Madigan Army Medical Center (US)
- ORCID
- PLYMATE, STEPHEN R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1991-01
- Volume
- 72
- Issue
- 1
- Pages
- 83-89
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2008509267
- Cited by
- 815
- References
- 38
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 25 · 2023: 25 · 2022: 28 · 2021: 38 · 2020: 27 · 2019: 25 · 2018: 18 · 2017: 25 · 2016: 25 · 2015: 30 · 2014: 22 · 2013: 27 · 2012: 18
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-18904)
- National Center for Research Resources (RR 00065, M01RR000065)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hyperinsulinemia, sex hormone-binding globulin, polycystic ovary syndrome, obesity, insulin resistance, diazoxide, leuprolide, GnRH agonist, testosterone, androstenedione, estradiol, estrone, glucose tolerance, insulin secretion, ovarian steroidogenesis, glucose-insulin interaction, insulin sensitivity index, insulin resistance index
- MeSH terms
- Adult, Androstenedione, Diazoxide, Estradiol, Estrone, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Gonadotropin-Releasing Hormone, Obesity, Polycystic Ovary Syndrome, Progesterone, Sex Hormone-Binding Globulin, Testosterone, Androstane-3,17-diol, Leuprolide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review